SCHEMBL5670922

SCHEMBL5670922

CCCCCNc1cn2ccccc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 1/20 0.48
HRH3 Q9Y5N1 1/20 0.45
NPC1 O15118 9/20 0.45
RAB9A P51151 9/20 0.45
ALDH1A1 P00352 6/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
KDM4E B2RXH2 4/20 0.45
PKM P14618 3/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
MAPT P10636 3/20 0.45
LMNA P02545 2/20 0.45
MAPK1 P28482 1/20 0.44
KCNH3 Q9ULD8 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
TP53 P04637 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
EPHX2 P34913 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7267811 0.74 PDE10A (0.55) TLR7HRH3NPC1RAB9AALDH1A1
SCHEMBL17962528 0.73 PTGS1 (0.50) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL14499072 0.73 PDE10A (0.54) TLR7HRH3NPC1RAB9AALDH1A1
SCHEMBL10647023 0.72 NPC1 (0.56) HRH3NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL20956301 0.72 TLR8 (0.44) TLR7NPC1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL11989037 0.70 PTGS1 (0.44) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL516003 0.70 TLR8 (0.51) NPC1RAB9AALDH1A1MAPTKCNH3
SCHEMBL9854177 0.69 HRH3 (0.43) TLR7HRH3NPC1RAB9AALDH1A1
SCHEMBL25027965 0.69 HRH3 (0.44) TLR7HRH3NPC1RAB9AALDH1A1
SCHEMBL9971243 0.68 PDE10A (0.59) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7196196-B2 Substituted imidazo[1, 2-a]-5,6,7,8-tetrahydropyridine-8-ones, method for their production and the use thereof for producing imidazo[1,2-a]pyridines BASF AKTIENGESELLSCHAFT (DE) 2007-03-27 US disclosed
US-20050020620-A1 Substituted imidazo[1, 2-a]-5,6,7,8-tetrahydropyridine-8-ones, method for their production and the use thereof for producing imidazo[1,2-a]pyridines BASF AKTIENGESELLSCHAFT (DE) 2005-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020620-A1 Substituted imidazo[1, 2-a]-5,6,7,8-tetrahydropyridine-8-ones, method for their production and the use thereof for producing imidazo[1,2-a]pyridines BTN3A1, DHPS, NISCH TLR7 2178/4885HRH3 1293/4885NPC1 4825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.